Lindbrook Capital, LLC Taro Pharmaceutical Industries LTD Transaction History
Lindbrook Capital, LLC
- $1.18 Billion
- Q3 2024
A detailed history of Lindbrook Capital, LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 142 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142
Previous 142
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TARO
# of Institutions
9Shares Held
17KCall Options Held
0Put Options Held
0-
Credit Suisse Ag Zurich, V813.1KShares$00.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL2KShares$00.0% of portfolio
-
Covington Capital Management750Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,711Shares$00.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA126Shares$00.0% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...